NASDAQ:NKTX

Nkarta Stock Predictions

Healthcare > Biotechnology

Buy NKTX

*Your capital is at risk

$2.72

-0.190 (-6.53%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

NKTX Prediction Chart

NKTX Predictions History

Latest community submissions for NKTX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Feb 16, 2021	$55.25 -0.68%	$55.63	X	99.32%	4
JS Pro	Oct 23, 2020	$26.85 -10.20%	$29.90	X	89.80%	0
Anyhony @Anyhony.5461	Oct 23, 2020	$36.00 +20.40%	$29.90	X	79.60%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NKTX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT NKARTA INC.

Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by